生物技术公司莫德纳(MRNA.US)今天盘中股价出现大跌,引发了市场的广泛关注。
数据显示,莫德纳股价盘中一度大跌5.04%,总市值蒸发约47亿美元。公司最新财报显示,第三季度营收18.62亿美元,净利润仅1300万美元,单季业绩表现远不及市场预期,增长动能明显放缓。尽管疫情后莫德纳疫苗业务仍是主要利润来源,但相关收入预计将逐步下滑,未来业务发展前景堪忧。
此外,投资者对公司拓展新业务的信心也不足。虽然莫德纳正加速推进多个新药研发,但由于技术壁垒高、竞争激烈、投入资金巨大,能否最终成功获批上市尚存重大不确定性。市场担心公司未来几年将面临业务转型的严峻挑战,从而引发投资者抛售潮。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.